AMR NEWS: Your Global Source for the Latest AMR Insights and Publications!

Search for:

Home » _News » Smart Innovations » Page 13

AMR news related to Smart Innovations

For scientists, researchers, and innovators committed to staying at the forefront of antimicrobial resistance, AMR Insights provides the most comprehensive, up-to-date overview of global news and breakthroughs. Access cutting-edge research, expert insights, and the latest developments to fuel your work and accelerate progress in the fight against AMR.

Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence

Indian Priority Pathogen List jointly developed by DBT and WHO India Office

Practical nanozymes discovered to fight antimicrobial resistance

Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria

NIH awards grants to support bacteriophage therapy research

Chemically modified and conjugated antimicrobial peptides against superbugs

New model can predict how bacteria develop antibiotic resistance

Antibiotics Currently in Global Clinical Development (update)

AMR Fund and Global Cohorts Working to Prevent Another Pandemic

Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates

Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations

Identification of Antimicrobial Resistance Mechanism May Lead to Novel Drug Targets

AMR research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic

Looking for Solutions to the Pitfalls of Developing Novel Antibacterials in an Economically Challenging System

Tracking the Pipeline of Antibiotics in Development

CARB-X IS FUNDING AFFINIVAX TO DEVELOP A NOVEL VACCINE TO PREVENT STAPHYLOCOCCUS AUREUS BACTERIAL INFECTIONS

Research pinpoints unique drug target in antibiotic resistant bacteria

Reducing antibiotic prescribing with rapid POC respiratory infection test

Resistance is rarely futile – reinvigorating the AMR ecosystem

New collaboration between PAR Foundation and the Global AMR R&D Hub

Malaria data opened up to combat drug resistance

Antibiotic Development Needs Economic Incentives

Understanding the Antibacterial Resistance: Computational Explorations in Bacterial Membranes

25 February 2021

Monitoring the Bacterial Response to Antibiotic and Time Growth Using Near-infrared Spectroscopy Combined with Machine Learning

25 February 2021

Engineered viruses can fight the rise of antibiotic-resistant bacteria

25 February 2021

AI-based mobile application to fight antibiotic resistance

24 February 2021

To Push or To Pull? In a Post-COVID World, Supporting and Incentivizing Antimicrobial Drug Development Must Become a Governmental Priority

24 February 2021

CARB-X IS FUNDING THE UNIVERSITY OF QUEENSLAND TO DEVELOP A NEW DRUG TARGETED TO LOW- AND MIDDLE-INCOME COUNTRIES

23 February 2021

X-factor to help antibiotics regain their spark

18 February 2021

Global Principles on Incentivizing Antibiotic R&D

18 February 2021

The AMR Action Fund announces its first non-industry investments, raising an additional US$140 million toward addressing antimicrobial resistance (AMR)

18 February 2021

The AMR Action Fund announces appointment of CEO, Henry B. Skinner, PhD

17 February 2021

Adaptive Phage Therapeutics Announces FDA Clearance of IND Application for PhageBank™ for the Treatment of Prosthetic Joint Infections

13 February 2021

GARDP welcomes additional funding from UK to develop new treatment for gonorrhoea

11 February 2021

Antibiotic stewardship in direct-to-consumer telemedicine consultations lead to high adherence to best practice guidelines and a low prescription rate

4 February 2021

CARB-X is funding French biotech Mutabilis to develop a new class of antibacterials to treat infections caused by carbapenem-resistant Enterobacterales

2 February 2021

CARB-X is funding the development of avails medical’s rapid antibiotic susceptibility testing technology

29 January 2021

Antimicrobial-specific response from resistance gene carriers studied in a natural, highly diverse microbiome

28 January 2021

The state of bioinformatics in the fight against AMR

26 January 2021

Singapore designs tool to investigate hospital borne bacterial infections

23 January 2021

Exploring Prediction of Antimicrobial Resistance Based on Protein Solvent Accessibility Variation

22 January 2021

Bacteriophage Therapy Market Update 2021

22 January 2021

Phage therapy offers hope in fight against antibiotic resistance and superbugs

22 January 2021

Irish soil can offer more hope in fight against antibiotic resistance, researchers show

22 January 2021

Letter: A better way to spend Ineos’ Oxford gift

22 January 2021

Fast-tracking the use of copper in the NHS to tackle AMR

19 January 2021

Ineos gives Oxford £100m to set up antibiotic research institute

18 January 2021

Taiwan develops microfluidic platform for rapid screening of diseases

18 January 2021

Research uncovers strategy to revert antibiotic-resistance in dangerous superbugs

18 January 2021

A framework for identifying the recent origins of mobile antibiotic resistance genes

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed